Title: Congenital Syphilis
1Congenital Syphilis
- Irina Tabidze, MD, MPH and
- Thad Zajdowicz, MD, MPH
- STD/HIV Division
- Chicago Dept of Public Health
2Congenital Syphilis (CS)
- Syphilis is a chronic infection caused by the
spirochete Treponema pallidum, which is of
particular concern during pregnancy because of
the risk of transplacental infection of the
fetus. - Congenital infection is associated with several
adverse outcomes, including - -Perinatal death
- -Premature delivery
- -Low birth weight-Congenital anomalies
3Modes of Transmission
- Sexual contact.
- Trans-placental passage from infected mother.
- Contact with lesion at the time of delivery.
- The risk of developing syphilis after exposure is
about 40.
4 Risk Factors for CS
- Lack of or inadequate prenatal care.
- Maternal substance abuse.
- Failure to repeat a serological test for syphilis
in the third trimester. - Treatment failure.
- Inadequate access to Sexually Transmitted
Diseases (STD) clinics and STD outreach
activities.
5Epidemiology of CS
- Incidence of CS reflects the rate of syphilis in
women of childbearing age. - Peaks in CS occur one year after peaks in PS
syphilis in women.
6Congenital syphilis Rates for infants lt1 year
of age US, 19812002 and the Healthy People 2010
objective
Rate (per 100,000 live births)
125
Cong. Syphilis
2010 Objective
100
75
50
25
0
1981
83
85
87
89
91
93
95
97
99
2001
Note The Healthy People 2010 objective for
congenital syphilis is 1.0 case per 100,000 live
births. The surveillance case definition for
congenital syphilis changed in 1988.
7Congenital syphilis Reported cases for infants
lt1 year of age and rates of P S syphilis among
women US, 19702002
PS rate (per 100,000 population)
CS cases (in thousands)
20
7.5
Kaufman Criteria
16
6.0
CDC Surveillance
Definition
12
4.5
PS Syphilis
8
3.0
Congenital
4
1.5
Syphilis
0
0.0
1970
75
80
85
90
95
2000
Note The surveillance case definition for
congenital syphilis changed in 1988.
8Syphilis in Newborns
- Two-thirds of live-born neonates with CS are
asymptomatic at births. - Overt infection can manifest in the fetus, the
newborn, or later in childhood. - The infant may have many or even no signs until
6-8 weeks of life (delayed form). - Clinical manifestations after birth are divided
arbitrarily into - - Early CS (lt2 years of age) and
- - Late CS ( gt2 years of age)
9Clinical Manifestations of Early CS
- Condyloma Lata
- Maculopapular rash
- Hepatosplenomegaly
- Jaundice due to the hepatitis
- Anemia
- Osteochondritis
- Snuffles
- Pseudoparalysis
- Lymphadenopathy
- Mucous patches
10Congenital Syphilis
11(No Transcript)
12Congenital Syphilis
13Congenital Syphilis
14Congenital Syphilis
15Clinical Manifestations of Late CS
- Hutchinsons triad (63)
- -Hutchinsons teeth (blunted upper incisors)
- -Interstitial keratitis
- -VII nerve deafness
- Frontal bossae (bony prominences of the forehead)
(87)
- Saddle nose (74)
- Defect of hard pallet
- Cluttons joints (bilateral painless swelling of
knees) - Saber chins
- Short maxillas
- Protruding mandible
16Congenital Syphilis
Hutchinsons Triad (late congenital
syphilis) Interstitial keratitis Teeth
abnormalities Deafness
17Congenital Syphilis
18Cluttons Joints
19Saddle Nose
20Sabre Shins
21Laboratory Diagnosis
- Direct visualization
- Darkfield examination of exudate
- Direct fluorescent antibody to T. pallidum
- Serologic testing
- - Nontreponemal Antibody tests (VDRL test and
RPR test) - - Treponemal Antibody tests (FTA-ABS and MHA-TP)
22Interpretation of the Syphilis Serology of
Mothers their Infants
Treponemal Test
Nontreponemal Test
Interpretation No syphilis or incubating
syphilis in the mother and infant
Infant
Infant
Mother
Mother
-
-
-
-
-
-
No syphilis in mother
Maternal syphilis with possible infant infection
or -
Recent or previous syphilis in the mother
possible infection in infant
-
-
Mother successfully treated for
syphilis before or early in
pregnancy
23Maternal Treatment
- Penicillin is the gold standard for the treatment
of syphilis. - Pregnant women with syphilis should be treated
with the appropriate penicillin regimen according
to their stage of disease. - Sexually Transmitted Diseases Treatment
Guidelines 2002. MMWR 2002 51 (No. RR-6)
19-23
24Treatment of Infants
- Sexually Transmitted Diseases Treatment
Guidelines 2002. MMWR 2002 51 (No. RR-6)
26-28
25Follow-up evaluation
- Non-treponemal antibody serologic testing should
be checked at 1, 3, 6, 12 and 24 months following
treatment. - Titers should decrease four-fold by 6 months post
therapy and become non-reactive by 12 to 24
months. - Titers that show a four-fold rise or do not
decrease suggest either treatment failure or
re-infection.